Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review.

Grenet G, Eskandari R, Ko J, Adams SP, Salzwedel DM, Heran BS, Ambasta A, Bassett K, Thompson W

DOI: 10.1136/bmjdrc-2026-006225
Published: 2026 Aug 19
Container: BMJ open diabetes research & care
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjdrc-2026-006225,
  title = {Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review.},
  author = {Grenet G and Eskandari R and Ko J and Adams SP and Salzwedel DM and Heran BS and Ambasta A and Bassett K and Thompson W},
  year = {2026},
  journal = {BMJ open diabetes research \& care},
  doi = {10.1136/bmjdrc-2026-006225},
  url = {https://doi.org/10.1136/bmjdrc-2026-006225}
}

RIS

TY  - JOUR
TI  - Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review.
AU  - Grenet G
AU  - Eskandari R
AU  - Ko J
AU  - Adams SP
AU  - Salzwedel DM
AU  - Heran BS
AU  - Ambasta A
AU  - Bassett K
AU  - Thompson W
PY  - 2026
JO  - BMJ open diabetes research & care
DO  - 10.1136/bmjdrc-2026-006225
UR  - https://doi.org/10.1136/bmjdrc-2026-006225
ER  -

APA

G, G., R, E., J, K., SP, A., DM, S., BS, H., A, A., K, B., & W, T. (2026). Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review.. BMJ open diabetes research & care. https://doi.org/10.1136/bmjdrc-2026-006225

Source records

pubmed · retrieved 2026-09-26T02:28:46.411Z